New Clinical Trials Data Bank

Publication
Article
OncologyONCOLOGY Vol 14 No 5
Volume 14
Issue 5

The National Library of Medicine has started posting information about clinical trials in its new Clinical Trials

The National Library of Medicine has started posting information about clinical trials in its new Clinical Trials Data Bank (http://clinicaltrials.gov). At present, the new bank contains more data than had formerly been available on the NIH clinical trials website, and it will be expanded throughout 2000 to include trials sponsored by other federal agencies and the private sector. The trials included in the new data bank are only those conducted under an FDA investigational new drug application for serious or life-threatening diseases, such as cancer or AIDS. In conjunction with establishment of the data bank, the FDA has published draft guidance on what kind of information clinical trial sponsors must submit (www.fda.gov/cder/guidance/index.htm).

Recent Videos
Most central nervous system events with lorlatinib were grade 1 or 2 in the phase 3 CROWN trial.
Treatment with lorlatinib did not increase cardiovascular events among patients with ALK-positive non–small cell lung cancer in the CROWN trial.
Having all the necessary staff together, from medical oncologists to pharmacists, helps deliver the best possible outcomes to patients with cancer.
At 5 years, 60% of patients who received lorlatinib in the phase 3 CROWN study achieved progression-free survival.
Joseph C. Landolfi, DO, CPE, and Michelle Morrison, MPH, BSHA, RN, discuss how they can use their leadership roles to improve cancer care.
Prior studies, like the phase 3 VISION trial, may support the notion of combining radiopharmaceuticals with best supportive care.
Leadership of a new cancer center as part of JFK University Medical Center discuss how they can support frontline clinicians.
Related Content